Brief: Lavipharm signs long term agreement with Valeant Group
Nov 11 (Reuters) - Lavipharm SA LPHr.AT :
* Says signs long term agreement with Valeant Group
* Says agreement concerns exclusive promotion, distribution
and sale, in Greece and Cyprus, of analgesic Algon from
Valeant's unit PharmaSwiss Hellas
Source text: http://bit.ly/1GWNEl2
Further company coverage: LPHr.AT
(Reporting by Apostolos Kalantzis)
((APOSTOLOS.KALANTZIS@thomsonreuters.com;))
Recent news on Lavipharm SA
See all newsBrief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
Brief: Lavipharm H1 Adjusted EBITDA At EUR 7.7 Million, Up 29.4% YoY